- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05157880
Building Resiliency in Dyads of Patients With an ANI Admitted to the Neuro-ICU and Their Informal Caregivers
December 20, 2023 updated by: Ana-Maria Vranceanu, PhD, Massachusetts General Hospital
Recovering Together: Building Resiliency in Dyads of Patients With an Acute Brain Injury Admitted to the Neuroscience Intensive Care Unit and Their Informal Caregivers
The purpose of the present investigation is to test the efficacy of a brief (6 sessions) dyadic (patient and caregiver together) intervention to prevent chronic emotional distress in at risk dyads admitted to a Neuroscience Intensive Care Unit with an acute brain injury.
Through this study, we seek to solve the unmet need of preventing chronic emotional distress in Neuroscience Intensive Care Unit (NICU) dyads through a feasible, acceptable and credible program, and ideally improve the recovery trajectory and dyads' overall quality of life.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The goals of this study are to: 1) demonstrate the efficacy of Recovering Together for improving self-reported emotional distress (primary outcome), and post traumatic stress, mindfulness, coping, social support and other relevant outcomes (secondary outcomes); and 2) assess mechanisms (mediators and moderators) of improvement after intervention.
We will enroll and randomly assign 194 at risk dyads (97 per study group) to receive either the active intervention or educational control.
The trial is single blinded (assessors, patients and staff).
The trial will take place at the Massachusetts General Hospital NICU using our established methodology successfully implemented during the R21 pilot study.
Study clinicians will deliver 6, 30 minute sessions of active intervention or educational control (2 at bedside and 4 via live video after discharge) to each patient-caregiver dyad.
All participants will complete measures at baseline, after completion of program (6 weeks) and 3 months later.
They will also complete measures of emotional distress weekly, as well as measures assessing home practice.
Study Type
Interventional
Enrollment (Estimated)
388
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ana-Maria Vranceanu, PhD
- Phone Number: 617-724-4977
- Email: avranceanu@mgh.harvard.edu
Study Contact Backup
- Name: Emily Woodworth, BA
- Phone Number: 617-643-4123
- Email: ewoodworth@mgb.org
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02114
- Recruiting
- Massachusetts General Hospital (MGH)
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age 18 or older
- English fluency and literacy
- Patient with an informal caregiver available and willing to participate
- Hospitalized with any ANI within 6 weeks (patient) OR informal caregiver of a patient currently admitted with any ANI
- Patient and/or caregiver exhibit emotional distress on screening (using HADS D and/or HADS A scores > 7)
Exclusion Criteria:
- Permanent cognitive impairment (including severe hearing impairment) or aphasia that makes participation impossible
- Short form of Mini-Mental State Exam (SMMSE) score <4 (If SMMSE <4, nursing team decides whether or not the patient can meaningfully participate)
- Glasgow Coma Scale (GCS) score <10
- Terminal diagnosis
- Lack of access to internet and/or a device with a camera
- Current untreated or unstable severe mental health conditions like bipolar disorder, schizophrenia, or active substance use
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Experimental Patient-Caregiver Dyads
There will be 6 sessions with 2 general sessions delivered in person at bedside in the NICU (or virtual depending on COVID and discharge status) and 4 tailored specific sessions (chosen from by the dyads from 6 available modules) to be delivered via live video using Zoom.
Content will be primarily skills.
|
In the skills-based intervention group, sessions focus on developing skills to cope and manage ANI related stressors.
The intervention will be tailored consistent with AHA recommendations for ANI skills-based interventions and will include 2 general and 4 specific modules.
It is anticipated that the intervention will have 6 sessions with 2 general sessions delivered, in person if possible, within the NICU, or through live video using Zoom if patients leave the hospital before sessions occur, and 4 tailored specific sessions (chosen from by the dyads from 6 available modules) to be delivered via live video using Zoom.
Other Names:
Those in the educational program will receive general health information that mimics the skills-based intervention, but without teaching any of the resiliency or interpersonal communication skills that are hypothesized to be responsible for improvement in emotional distress.
There will also be 6 sessions, 2 in-person dyadic visits in the NICU and 4 dyadic virtual visits following discharge.
The educational program group will not have the opportunity to specify which modules they would like to take; the modules will be predetermined.
All participants will receive medical care as determined by their medical team.
Other Names:
|
Active Comparator: Control Patient-Caregiver Dyads
There will be 6 sessions with 2 general sessions delivered in person at bedside in the NICU (or virtual depending on COVID and discharge status) and 4 tailored specific sessions (chosen from by the dyads from 6 available modules) to be delivered via live video using Zoom.
Content will be primarily educational.
|
In the skills-based intervention group, sessions focus on developing skills to cope and manage ANI related stressors.
The intervention will be tailored consistent with AHA recommendations for ANI skills-based interventions and will include 2 general and 4 specific modules.
It is anticipated that the intervention will have 6 sessions with 2 general sessions delivered, in person if possible, within the NICU, or through live video using Zoom if patients leave the hospital before sessions occur, and 4 tailored specific sessions (chosen from by the dyads from 6 available modules) to be delivered via live video using Zoom.
Other Names:
Those in the educational program will receive general health information that mimics the skills-based intervention, but without teaching any of the resiliency or interpersonal communication skills that are hypothesized to be responsible for improvement in emotional distress.
There will also be 6 sessions, 2 in-person dyadic visits in the NICU and 4 dyadic virtual visits following discharge.
The educational program group will not have the opportunity to specify which modules they would like to take; the modules will be predetermined.
All participants will receive medical care as determined by their medical team.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Emotional Distress
Time Frame: 0 weeks, 1 week, 2 weeks, 3 weeks, 4 weeks, 5 weeks, 6 weeks, 3 months
|
Hospital Depression and Anxiety Scale total score (HADS); 0-21 for each subscale (anxiety and depression), higher scores indicate greater anxiety or depression
|
0 weeks, 1 week, 2 weeks, 3 weeks, 4 weeks, 5 weeks, 6 weeks, 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Post-Traumatic Stress
Time Frame: 0 weeks, 6 weeks, 3 months
|
Post-Traumatic Stress Disorder Checklist - Specific Event (PCL-S); 17-85, higher scores indicate greater post-traumatic stress
|
0 weeks, 6 weeks, 3 months
|
Change in Resiliency Factors (Mindfulness - curiosity and de-centering)
Time Frame: 0 weeks, 6 weeks, 3 months
|
Toronto Mindfulness Scale-Trait (TMS-Trait); 0-52, higher scores indicate greater perceived mindfulness (specifically curiosity and de-centering)
|
0 weeks, 6 weeks, 3 months
|
Change in Resiliency Factors (Mindfulness)
Time Frame: 0 weeks, 6 weeks, 3 months
|
Cognitive and Affective Mindfulness Scale (CAMS); 12-48, higher scores indicate greater perceived mindfulness
|
0 weeks, 6 weeks, 3 months
|
Change in Resiliency Factors (Individual Coping)
Time Frame: 0 weeks, 6 weeks, 3 months
|
Measure of Current Status Part A (MOCS-A); 0-52; higher scores indicate greater perceived ability to cope
|
0 weeks, 6 weeks, 3 months
|
Change in Resiliency Factors (Dyadic Coping)
Time Frame: 0 weeks, 6 weeks, 3 months
|
Dyadic Coping Inventory (DCI); 35-175; higher scores indicate greater perceived coping in the context of a relationship
|
0 weeks, 6 weeks, 3 months
|
Change in Interpersonal Factors (perceived social support)
Time Frame: 0 weeks, 6 weeks, 3 months
|
Interpersonal Support Evaluation List-12 (ISEL-12); 0-48, higher scores indicate greater perceived social support
|
0 weeks, 6 weeks, 3 months
|
Change in Interpersonal Factors (avoidant or anxious communication)
Time Frame: 0 weeks, 6 weeks, 3 months
|
Experiences in Close Relationships Scale short form (ECR-S); 7-42, higher scores indicate greater avoidant or anxious communication
|
0 weeks, 6 weeks, 3 months
|
Change in Interpersonal Factors (dyadic strain and positive interpersonal interactions)
Time Frame: 0 weeks, 6 weeks, 3 months
|
Dyadic Relationship Scale (DRS); Patient version: 10-40, caregiver version: 11-44, dyadic strain subscale: higher scores indicate greater levels of strain, positive dyadic interaction subscale: higher scores indicate greater levels of positive interaction
|
0 weeks, 6 weeks, 3 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Demographic Factors (potential moderators)
Time Frame: 0 weeks
|
Age; biological sex; gender; race/ethnicity; educational level; employment status; occupation; income; marital status; prior ANI status; mental health history; psychotropic medications; medical comorbidities; satisfaction with medical staff (analog scale 0-10)
|
0 weeks
|
Change in Independence in activities of daily living (potential moderator)
Time Frame: 0 weeks, 6 weeks, 3 months
|
Barthel Score; 0-100, higher scores indicate greater independence
|
0 weeks, 6 weeks, 3 months
|
Change in Degree of disability or dependence (potential moderator)
Time Frame: 0 weeks, 6 weeks, 3 months
|
Modified Rankin; 0-6, higher scores indicate greater disability
|
0 weeks, 6 weeks, 3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 10, 2021
Primary Completion (Estimated)
March 1, 2026
Study Completion (Estimated)
March 1, 2026
Study Registration Dates
First Submitted
October 28, 2021
First Submitted That Met QC Criteria
December 1, 2021
First Posted (Actual)
December 15, 2021
Study Record Updates
Last Update Posted (Actual)
December 21, 2023
Last Update Submitted That Met QC Criteria
December 20, 2023
Last Verified
December 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2021P001943
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Emotional Distress
-
Peking UniversityNot yet recruitingEmotional Disorder | Emotional DistressChina
-
Xinghua LiuNot yet recruiting
-
Peking UniversityNot yet recruitingEmotional DistressChina
-
Peking UniversityNot yet recruiting
-
The University of Hong KongNot yet recruiting
-
Peking UniversityNot yet recruitingEmotional DistressChina
-
University of Wisconsin, MadisonRecruiting
-
Peking UniversityCompleted
-
Peking UniversityNot yet recruiting
-
Peking UniversityNot yet recruiting
Clinical Trials on Recovering Together
-
Massachusetts General HospitalCompletedAcute Brain InjuriesUnited States
-
York UniversityMcMaster University; University of TorontoCompletedFamily Conflict | Internet-Based InterventionCanada
-
The University of Texas Health Science Center,...Completed
-
York UniversityMcMaster University; University of TorontoActive, not recruitingMarital Relationship | Family Conflict | Internet-Based Intervention | Interparental Conflict | Marital ConflictCanada
-
University of ConnecticutNational Heart, Lung, and Blood Institute (NHLBI); Worcester Polytechnic InstituteCompleted
-
University of British ColumbiaPublic Health Agency of Canada (PHAC); The Bridge Youth and Family Services...CompletedOverweight and Obesity | Health Knowledge, Attitudes, PracticeCanada
-
Caroline RowlandCompletedLanguage DevelopmentUnited Kingdom
-
VA Office of Research and DevelopmentVA Boston Healthcare SystemCompletedIntimate Partner Violence | Self-efficacyUnited States
-
Dominique JANUELRecruiting
-
Michigan State UniversityUniversity of Michigan; Wake Forest University Health Sciences; Babes-Bolyai...CompletedUsual Care | Telemedicine: Smoking Cessation App Only | Telemedicine: Smoking Cessation Counseling | Telemedicine: App + CounselingRomania